| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
16,040 |
162,488 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-15 |
4 |
D |
$83.57 |
$406,234 |
D/D |
(4,861) |
146,448 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-22 |
4 |
D |
$81.36 |
$472,864 |
D/D |
(5,812) |
156,676 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-03-22 |
4/A |
D |
$81.36 |
$474,736 |
D/D |
(5,835) |
156,653 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-04-02 |
4 |
AS |
$80.12 |
$801,200 |
D/D |
(10,000) |
156,676 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-04-02 |
4 |
OE |
$26.49 |
$337,851 |
D/D |
10,000 |
163,326 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
157,101 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-04 |
4 |
D |
$92.07 |
$178,063 |
D/D |
(1,934) |
155,167 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-14 |
4 |
AS |
$90.00 |
$2,790,085 |
D/D |
(31,000) |
155,167 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-06-14 |
4 |
OE |
$21.51 |
$1,067,380 |
D/D |
31,000 |
175,848 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-08-24 |
4 |
S |
$99.00 |
$1,237,500 |
D/D |
(12,500) |
142,667 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-08-27 |
4 |
S |
$100.00 |
$1,250,000 |
D/D |
(12,500) |
130,167 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-01 |
4 |
D |
$94.76 |
$109,353 |
D/D |
(1,154) |
144,700 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,687 |
145,854 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-04 |
4 |
AS |
$95.00 |
$208,620 |
D/D |
(2,196) |
142,504 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-15 |
4 |
D |
$94.53 |
$892,647 |
D/D |
(9,443) |
133,061 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
12,840 |
145,901 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-18 |
4 |
AS |
$94.09 |
$902,982 |
D/D |
(9,597) |
136,304 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-22 |
4 |
D |
$88.05 |
$513,860 |
D/D |
(5,836) |
130,468 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-03-25 |
4 |
AS |
$87.86 |
$521,186 |
D/D |
(5,932) |
124,536 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
124,845 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
13,136 |
137,981 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-03-13 |
4 |
D |
$84.50 |
$886,912 |
D/D |
(10,496) |
127,485 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
18,220 |
145,705 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2020-03-20 |
4 |
D |
$73.05 |
$426,320 |
D/D |
(5,836) |
139,869 |
0 |
- |
|
294 Records found
|
|
Page 7 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
